191
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Vision-Related Quality of Life in Patients with Chronic Central Serous Chorioretinopathy

, , , , , & show all
Pages 272-275 | Received 09 Jul 2013, Accepted 20 Aug 2013, Published online: 28 Oct 2013

REFERENCES

  • Bennett G. Central serous retinopathy. Br J Ophthalmol 1955;39:605–618
  • Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina 1987;7:111–131
  • Şahin A, Bez Y, Kaya MC, et al. Psychological distress and poor quality of life in patients with central serous chorioretinopathy. Semin Ophthalmol 2013 Jun 12 . [Epub ahead of print]. DOI: 10.3109/08820538.2013.793728
  • Mangione CM, Lee PP, Gutierrez PR, et al; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001;119:1050–1058
  • Toprak AB, Eser E, Guler C, et al. Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiol 2005;12:259–269
  • Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967;63:1–139
  • Garg SP, Dada T, Talwar D, et al. Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 1997;81:962–964
  • Türkcü FM, Yüksel H, Şahin A, et al. Effects of Smoking on Visual Acuity of Central Serous Chorioretinopathy Patients. Cutaneous and Ocular Toxicology. 2013 Jul 10 . [Epub ahead of print]. DOI: 10.3109/15569527.2013.810633
  • Bouzas EA, Scott MH, Mastorakos G, et al. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 1993;111:1229–1233
  • Türkcü FM, Yüksel H, Yüksel H, et al. Serum dehydroepiandrosterone sulphate, total antioxidant capacity, and total oxidant status in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2013 Jun 8 . [Epub ahead of print]. DOI: 10.1007/s00417-013-2396-2
  • Conrad R, Weber NF, Lehnert M, et al. Alexithymia and emotional distress in patients with central serous chorioretinopathy. Psychosomatics 2007;48:489–95
  • Garg SP, Dada T, Talward D, et al. Psychological factors in the etiopathogenesis of central serous chorioretinopathy. Annals of Ophthalmology 2005;37:201–205
  • Frick KD, Drye LT, Kempen JH, et al; Multicenter Uveitis Steroid Treatment-MUST Trial Research Group. Associations among visual acuity and vision- and health-related quality of life among patients in the multicenteruveitis steroid treatment trial. Invest Ophthalmol Vis Sci 2012;53:1169–1176
  • Lotery A, Xu X, Zlatava G, Loftus J. Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: Results from the UK cohort of a five-country cross-sectional study. Br J Ophthalmol 2007;91:1303–1307
  • Klein R, Moss SE, Klein BE, et al. The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 2001;119:733–740
  • Awdeh RM, Elsing SH, Deramo VA, et al. Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Br J Ophthalmol 2010;94:319–323
  • Orr P, Rentz AM, Margolis MK, et al. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Invest Ophthalmol Vis Sci 2011;52:3354–3359

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.